The simplified mantle cell lymphoma international prognostic index predicts overall survival but not progression-free survival in patients with mantle cell lymphoma treated with fludarabine and cyclophosphamide±rituximab: results of a randomized phase II trial-Reference-Cited by-同舟云学术

The simplified mantle cell lymphoma international prognostic index predicts overall survival but not progression-free survival in patients with mantle cell lymphoma treated with fludarabine and cyclophosphamide±rituximab: results of a randomized phase II trial

Published:2009-01 Issue:10 Volume:50 Page:1709-1711
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Eve Heather E.,Gambell Jo,Smith Paul,Qian Wendi,Rule Simon A. J.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190903186494

Reference9 articles.

1. A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

2. Follicular Lymphoma International Prognostic Index

3. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

4. Response: Statistical power and validation of the MIPI

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in Japan;British Journal of Haematology;2015-05-07

3. Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network;Journal of Clinical Oncology;2014-05-01

4. Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database;Leukemia & Lymphoma;2013-08-13

5. ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma;Annals of Oncology;2013-04